18 reports

  • MOLECULAR DIAGNOSTIC TEST - BIPOLAR DISORDER - PRODUCT STATUS
  • MOLECULAR DIAGNOSTIC TEST - BIPOLAR DISORDER - PRODUCT DESCRIPTION

SMA AFFECTS APPROXIMATELY ONE IN EVERY ##, ## INFANTS, WHILE ONE IN ## PEOPLE IS A CARRIER FOR THE DISORDER.

  • Clinical Trial
  • Hospital
  • Mental Health
  • Molecular Diagnostics
  • AutoGenomics, Inc.

The dividend will be payable on January ##, 2018, to stockholders of record on December ##, 2017.

  • Clinical Trial
  • Drug Development
  • Molecular Diagnostics
  • Point Of Care Testing
  • bioMerieux S.A.

Radhakrishnan has significant experience across a broad range of therapeutic areas, including several diseases and disorders within CNS such as multiple sclerosis, Alzheimer' s disease, neuropathic pain, spinal muscular atrophy, schizophrenia, major depression, bipolar

  • Diagnostics
  • Drug Development
  • Molecular Diagnostics
  • United States
  • Company

It also offers treatments for acid reflux disease, infectious diseases, bipolar I disorder, schizophrenia, alzheimer' s disease, epilepsy, migraine prevention and treatment.

  • Healthcare
  • Medical Biotechnology
  • Molecular Diagnostics
  • Pharmaceutical
  • United States

ABILIFY ALSO HAS PEDIATRIC USES IN SCHIZOPHRENIA AND BIPOLAR DISORDER, AMONG OTHERS.

  • Molecular Diagnostics
  • Market Size
  • Amgen Inc.
  • Merck & Co., Inc.
  • Novartis AG

RADHAKRISHNAN HAS SIGNIFICANT EXPERIENCE ACROSS A BROAD RANGE OF THERAPEUTIC AREAS, INCLUDING SEVERAL DISEASES AND DISORDERS WITHIN CNS SUCH AS MULTIPLE SCLEROSIS, ALZHEIMER' S DISEASE, NEUROPATHIC PAIN, SPINAL MUSCULAR ATROPHY, SCHIZOPHRENIA, MAJOR DEPRESSION, BIPOLAR

  • Allergy
  • Molecular Diagnostics
  • Canada
  • North America
  • Forecast

THE FOLLOWING LISTS THE MAIN DEVELOPMENT ADVANCES ACHIEVED DURING FY2016: SUBMITTED APPLICATIONS FOR APPROVAL OF EXTENDED-RELEASE TABLETS OF QUETIAPINE FUMARATE (GENERIC NAME, DEVELOPMENT CODE: FK##E) FOR THE INDICATION OF THE IMPROVEMENT OF DEPRESSIVE SYMPTOMS ASSOCIATED WITH BIPOLAR

  • Genetic Testing
  • Molecular Diagnostics
  • East Asia
  • Japan
  • Forecast

LUNDBECK AS Alzheimer' s disease, depression, Parkinson' s disease, schizophrenia, alcohol dependence, anxiety, bipolar I disorder, epilepsy and Huntington' s disease among others.

  • Chronic Disease
  • Molecular Diagnostics
  • Company
  • Product Initiative
  • HanAll Biopharma Co., Ltd.

The company' s product pipeline comprises DUR-## indicated for treatment of acute organ injuries and metabolic/ lipid disorders; Remoxy, indicated for chronic pain; Posimir, indicated for post-operative pain; Eladur, indicated for post herpetic neuralgia; Oradur, indicated for chro

  • Molecular Diagnostics
  • Pathology
  • Pharmaceutical
  • Renal Disease
  • Therapy

THE COMPANY' S PRODUCT PIPELINE COMPRISES DUR-## INDICATED FOR TREATMENT OF ACUTE ORGAN INJURIES AND METABOLIC/ LIPID DISORDERS; REMOXY, INDICATED FOR CHRONIC PAIN; POSIMIR, INDICATED FOR POST-OPERATIVE PAIN; ELADUR, INDICATED FOR POST HERPETIC NEURALGIA; ORADUR, INDICATED FOR CHRO

  • Digestive System Disorder
  • Molecular Diagnostics
  • Pharmaceutical
  • Therapy
  • Product Initiative

Its products are used in the treatment of diseases such as Alzheimer' s disease, depression, Parkinson' s disease, schizophrenia, alcohol dependence, anxiety, bipolar I disorder, epilepsy and Huntington' s disease among others.

  • Dementia
  • Molecular Diagnostics
  • Pharmaceutical
  • Company
  • Product Initiative

THE LARGEST SEGMENTS OF THIS MARKET IN ARE ONCOLOGY, GENETIC OVERVIEW Chapter ##: Executive Summary (INHERITED) DISORDERS, AND INFECTIOUS DISEASE, BUT LABORATORY DEVELOPED TESTS CAN BE DEVELOPED AND USED FOR VIRTUALLY ALL DISORDERS.

  • Health Services
  • Laboratory
  • Molecular Diagnostics
  • United States
  • Company

THE COMPANY' S LEAD PRODUCT ADASUVE (STACCATO LOXAPINE) IS INDICATED FOR THE TREATMENT OF AGITATION ASSOCIATED WITH SCHIZOPHRENIA OR BIPOLAR I DISORDER.

  • Cancer
  • Molecular Diagnostics
  • Pharmaceutical
  • Product Initiative
  • Amgen Inc.
  • PROGNOSTIC ASSAY - PROSTATE CANCER - PRODUCT DESCRIPTION
  • PROGNOSTIC ASSAY - PROSTATE CANCER - PRODUCT STATUS

AltheaDx offers products and services to therapeutic areas of hypertension, musculoskeletal pain, hyperhomocysteinemia, bipolar disorder, neuropathic pain, anxiety, arrhythmia, depression, arthritis and migraine.

  • Clinical Trial
  • Diagnostics
  • Molecular Diagnostics
  • Prostate Cancer
  • bioMerieux S.A.
  • Pipeline Programs Targeting G Protein-Coupled Receptor 78
  • Data for Probable G Protein-Coupled Receptor 52 as

Meta-analysis and comparison with bipolar disorder.

  • Mental Health
  • Molecular Diagnostics
  • Pathology
  • Psychotic Disorder
  • Deals & Alliance

Includes testing for drugs to treat depression, bipolar disorder, anxiety, psychosis, ADHD, musculoskeletal pain, arthritis, migraine, neuropathic pain, and seizure disorder.

  • Cancer
  • Molecular Diagnostics
  • Company
  • Company Operations
  • QIAGEN N.V.
  • DIGITAL PCR

These would include psychotropic drugs (e. g., antidepressants, bipolar disorder drugs, etc. ), antibiotic regimens, antiviral regimens (such as HIV therapy) and cancer chemotherapy (noninfusive).

  • Medical Biotechnology
  • Molecular Diagnostics
  • United States
  • Company
  • QIAGEN N.V.

The disorders autism, attention deficit-hyperactivity disorder or ADHD, bipolar disorder, major depressive disorder and schizophrenia - are considered distinct problems.

  • Genome Sequencing
  • Genomics
  • Molecular Diagnostics
  • Neurological Disorder
  • Illumina, Inc.